Addiction is yet another area where GLP-1s might be effective. Preliminary evidence looks promising, but questions remain.
Some of what RFK Jr. says about obesity prevention isn't new. But after having coined the catchy MAHA acronym, it’s likely ...
Obese people ‘will have to wait’ for Mounjaro amid carefully managed NHS rollout - The decision will help ‘protect other ...
MILLIONS of Brits “will have to wait” to take a lifesaving fat loss jab dubbed the “King Kong of weight loss drugs”. Fewer ...
NHS patients waiting for an obesity drug may be given a blow as its revealed that fewer than 10 per cent of those eligible ...
After this, the situation will be reviewed by Nice, who will provide further guidance on the rollout. Mounjaro is a ...
They need to be prescribed by a healthcare professional alongside programmes that help people lose weight and live healthier ...
While B-ALL is the most common childhood cancer and one of the most treatable, some patients face grim outcomes after they ...
Pharmaceutical giants Eli Lilly and Company & Novo Nordisk A/S face challenges in the obesity market despite promising data.
Mounjaro is the brand name for a drug called tirzepatide, which is a glucagon-like peptide-1 (GLP-1) that helps to lower ...
In a randomized controlled trial of people with type 2 diabetes, albuminuria, and estimated glomerular filtration rate (eGFR) between 25 and 75 mL/min/1.73 m2, subcutaneous semaglutide reduced the ...
Amylyx (AMLX) announced the design of its pivotal Phase 3 LUCIDITY clinical trial for avexitide, an investigational, first-in-class ...